| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.064 | 0.2 |